Form 4: Director Jasinski Acquires LMAT Shares via Vesting

Sentiment:

Insider Transaction Report


Lemaitre Vascular Director Lawrence J. Jasinski acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Summary

  • Lawrence J. Jasinski, a Director of Lemaitre Vascular Inc. (LMAT), reported changes in beneficial ownership.
  • On December 8, 2025, Mr. Jasinski acquired a total of 5 shares of LMAT common stock.
  • These shares were acquired upon the release of dividend equivalent rights (DERs) on a one-for-one basis.
  • Specifically, 2 shares were acquired in connection with the vesting of a restricted stock unit (RSU) award granted on December 8, 2023.
  • An additional 3 shares were acquired due to the vesting of a performance stock unit (PSU) award, also granted on December 8, 2023.
  • Following these transactions, Mr. Jasinski directly beneficially owns 4,779 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it reflects a director increasing their direct ownership in the company, albeit through the vesting of equity compensation rather than an open market purchase. This indicates continued alignment of interests.

Positives

  • The acquisition of shares by a director, even through vesting, aligns management's interests with those of shareholders.
  • Vesting of restricted and performance stock units indicates that previously set performance or time-based conditions have been met.

Future Outlook

This filing is a report of insider transactions and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports a routine insider transaction related to equity compensation and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

  • The acquisition of shares by Director Lawrence J. Jasinski through the vesting of equity awards is a related party transaction.

Stakeholder Impact

  • Shareholders may view the increase in director ownership, even through vesting, as a positive sign of continued commitment and alignment with shareholder interests.

Key Dates

DateDescription
12/08/2023Grant date of the restricted stock unit (RSU) and performance stock unit (PSU) awards.
12/08/2025Transaction date for the acquisition of common stock upon the release and vesting of dividend equivalent rights.
12/10/2025Date the Form 4 filing was signed.

Keywords

Lemaitre Vascular, LMAT, Form 4, Insider Transaction, Stock Acquisition, Restricted Stock Unit, Performance Stock Unit, Dividend Equivalent Rights, Director Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.